Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Innoviva (Nasdaq: INVA), a diversified holding company with a core royalties portfolio and a strong presence in critical care and infectious disease through Innoviva Specialty Therapeutics (IST), announced that its CEO, Pavel Raifeld, will participate in the Goldman Sachs 45th Annual Global Healthcare Conference. The event will take place in Miami, FL on June 10, 2024, at 1:20 p.m. Eastern Time. The session will be available via live webcast on the company's Investor Relations webpage and can be replayed for 90 days.

Positive

• Participation in a prestigious event like the Goldman Sachs 45th Annual Global Healthcare Conference.
• Exposure and potential networking opportunities for Innoviva's CEO, Pavel Raifeld.
• Availability of a live webcast, enhancing transparency and accessibility for investors.
• Replay option for 90 days, offering extended access to the information presented.

Negative

• No immediate financial or clinical data presented in the announcement.
• Potential over-reliance on the exposure from the event to influence stock performance.

BURLINGAME, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (Nasdaq: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on Monday, June 10, 2024 at 1:20 p.m. Eastern Time.

A live webcast of the fireside chat can be accessed under “Events & Presentations” in the Investor Relations section of the Company’s website at https://investor.inva.com/presentations-events. The webcast will be available for replay for 90 days following the event.

About Innoviva

Innoviva is a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in healthcare assets. Innoviva’s royalty portfolio includes respiratory assets partnered with Glaxo Group Limited (“GSK”). Innoviva is entitled to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva’s other innovative healthcare assets include infectious disease and critical care assets stemming from acquisitions of Entasis Therapeutics, including XACDURO® (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use approved for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex and the investigational zoliflodacin currently being developed for the treatment of uncomplicated gonorrhea, and La Jolla Pharmaceutical Company, including GIAPREZA® (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock and XERAVA® (eravacycline) for the treatment of complicated intra-abdominal infections in adults.

ANORO®, RELVAR® and BREO® are trademarks of the GSK group of companies.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240603242707/en/

Investors & Media:

Argot Partners

(212) 600-1902

innoviva@argotpartners.com

Source: Innoviva, Inc.

FAQ

What event will Innoviva's CEO participate in?

Pavel Raifeld, CEO of Innoviva, will participate in the Goldman Sachs 45th Annual Global Healthcare Conference.

When is Innoviva's fireside chat at the Goldman Sachs Healthcare Conference?

The fireside chat will take place on June 10, 2024, at 1:20 p.m. Eastern Time.

How can I watch Innoviva's CEO at the Goldman Sachs Healthcare Conference?

A live webcast will be available on Innoviva's Investor Relations webpage under 'Events & Presentations'.

How long will the webcast of Innoviva's session be available?

The webcast will be available for replay for 90 days following the event.

What is the stock symbol for Innoviva?

Innoviva's stock symbol is INVA.